CDC & FDA: Collaboration & Challenges — FSMA, Food Outbreaks, Pharmacy Compounding & Emerging Health Issues | January 29 | Atlanta, GA

CDC & FDA:  Collaboration & Challenges — FSMA, Food Outbreaks, Pharmacy Compounding & Emerging Health Issues | January 29 | Atlanta, GA

a session on compounding

3:30-5:00 p.m.

 

Roundtable Discussion – Identifying and

Responding to Medical-Product Associated

Illness Outbreaks (Focus on Pharmacy

Compounding)

 

 

Panelists will lead an interactive discussion on

recent developments in pharmacy compounding,

including how CDC and FDA have worked together

to respond to contaminated product. Panelists will

also discuss the future of pharmacy compounding

and agency roles in finding and responding to

product quality problems and their collaboration on

investigating outbreaks of illness connected to

medical products.

 

Joseph F. Perz, DrPH, Ambulatory and Long Term

Care, Prevention and Response Branch, Division of

Healthcare Quality Promotion, CDC

 

William Kitchens, Partner, Arnall Golden Gregory,

LLP

 

T.C. Spencer Pryor, Partner, Alston & Bird, LLP

Polly J. Price, Professor of Law, Emory University

School of Law